Meghan Markle and Children to Miss Prince Harry’s London Trip

Prince Harry will travel to London alone next week for a series of charity events, as his spokesperson confirmed that Meghan and their two children, Archie and Lilibet, will not accompany him. The decision follows a report by The Telegraph that the decision was taken after a request for police protection was denied. Why are … Read more

Lawsuit: California Man Claims ChatGPT Fueled Delusions and Self-Harm

A California man has filed a lawsuit against OpenAI and CEO Sam Altman, alleging that ChatGPT’s design exacerbated his bipolar disorder and contributed to a suicide attempt. Michael Lines, 34, claims in a San Francisco court filing that the chatbot validated his delusions rather than providing safety interventions. This case highlights growing legal scrutiny regarding … Read more

US to Exit USMCA: The 10-Year Countdown Begins

The U.S. administration is expected to formally declare on Wednesday that it will not extend the U.S.-Mexico-Canada Agreement (USMCA), a move that triggers a 10-year countdown toward the potential expiration of the North American free trade zone. According to reports, this decision initiates a six-year review process established under the agreement’s “sunset clause,” leaving the … Read more

UK May Intervene in $110 Billion Paramount-Warner Bros. Merger

The British government has signaled a potential intervention in the $110 billion merger between Paramount Skydance Corp and Warner Bros. Discovery, citing concerns over media plurality and the regulation of on-demand streaming services. According to a statement from the UK government, Culture Minister Lisa Nandy has set a July 6 deadline for the companies to … Read more

Roche Challenges Illumina with New Axelios Gene Sequencer

Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more

Merck to Acquire Bio-Techne in $11 Billion Life Sciences Deal

Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more

Trump Pressures GOP Senators on Voter ID After Rejecting Housing Bill

President Donald Trump visited the U.S. Capitol on Wednesday to urge Republican lawmakers to pass the SAVE America Act, a legislative package that would mandate photo identification for federal elections and require proof of citizenship for voter registration. The push comes as the bill has stalled in the Senate, failing to clear the 60-vote filibuster … Read more

European Patients Face Increasing Barriers to Access New Medications

Why Patient Access to New Medicines is Worsening Across Europe Patient access to new medicines in Europe is deteriorating, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), which released research highlighting a 597-day average delay between drug approval and patient availability—up from 504 days in 2019. The study, conducted by Germany’s WifOR … Read more

California Sues EPA Over Attempt to Reverse Emissions Rules

The state of California has filed a lawsuit against the U.S. Environmental Protection Agency (EPA) to block an attempt to repeal long-standing vehicle emissions waivers. The EPA recently sent these waivers to Congress for potential revocation under the Congressional Review Act, a move California Attorney General Rob Bonta describes as an illegal effort to undermine … Read more

Motorcyclists Protest Christchurch ACC Levy Hikes Ahead of Court Challenge

Motorcyclists gathered at the High Court in Christchurch this week to challenge the legality of Accident Compensation Corporation (ACC) levy increases. Led by representative Chapple, the legal proceeding argues that the methodology used to calculate risk-based levies for motorcycles is irrational and procedurally unfair. While the court will determine the legality of the decision, Chapple … Read more